|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
24,270,000 |
Market
Cap: |
516.22(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$20.03 - $40.81 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Fulgent Genetics is a holding company. Through its subsidiaries, Co. is a technology company providing COVID-19 testing services, molecular diagnostic testing services and genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Co. has developed a proprietary technology platform allowing Co. to provide a test menu. Combining next generation sequencing with its technology platform, Co. performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels that can be tailored to meet customer needs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
29,577 |
54,115 |
78,957 |
Total Sell Value |
$0 |
$791,434 |
$1,639,451 |
$2,902,369 |
Total People Sold |
0 |
3 |
3 |
4 |
Total Sell Transactions |
0 |
6 |
19 |
36 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gao Hanlin |
Chief Scientific Officer |
|
2021-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
816,588 |
|
- |
|
Xie Jian |
Chief Operating Officer |
|
2021-03-15 |
4 |
S |
$104.10 |
$312,300 |
D/D |
(3,000) |
342,476 |
|
14% |
|
Bolger John C |
Director |
|
2021-03-09 |
4 |
S |
$101.62 |
$342,882 |
D/D |
(3,374) |
125 |
|
24% |
|
Bolger John C |
Director |
|
2021-03-09 |
4 |
OE |
$3.93 |
$16,384 |
D/D |
3,124 |
3,499 |
|
- |
|
Xie Jian |
Chief Operating Officer |
|
2021-03-09 |
4 |
S |
$102.65 |
$6,364,219 |
D/D |
(62,000) |
345,476 |
|
24% |
|
Kim Paul |
CFO and Treasurer |
|
2021-03-01 |
4 |
D |
$111.38 |
$44,886 |
D/D |
(403) |
172,951 |
|
- |
|
Xie Jian |
Chief Operating Officer |
|
2021-02-27 |
4 |
D |
$101.26 |
$40,808 |
D/D |
(403) |
407,476 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2021-02-15 |
4 |
D |
$161.09 |
$178,649 |
D/D |
(1,109) |
173,354 |
|
- |
|
Xie Jian |
Chief Operating Officer |
|
2021-02-15 |
4 |
D |
$161.09 |
$129,839 |
D/D |
(806) |
407,879 |
|
- |
|
Gao Hanlin |
Chief Scientific Officer |
|
2021-02-15 |
4 |
D |
$161.09 |
$48,810 |
D/D |
(303) |
813,088 |
|
- |
|
Xie Jian |
Chief Operating Officer |
|
2021-02-01 |
4 |
D |
$137.91 |
$69,507 |
D/D |
(504) |
408,685 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2020-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
100 |
174,463 |
|
- |
|
Ming Hsieh Trust |
10% Owner |
|
2020-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,895,115 |
|
93% |
|
Xie Jian |
Chief Operating Officer |
|
2020-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
22,500 |
409,189 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2020-12-10 |
4 |
S |
$51.94 |
$880,734 |
D/D |
(16,958) |
174,563 |
|
-70% |
|
Kim Paul |
CFO and Treasurer |
|
2020-12-09 |
4 |
S |
$51.60 |
$550,189 |
D/D |
(10,662) |
191,521 |
|
-83% |
|
Xie Jian |
Chief Operating Officer |
|
2020-12-02 |
4 |
S |
$46.00 |
$46,000 |
D/D |
(1,000) |
431,689 |
|
-89% |
|
Xie Jian |
Chief Operating Officer |
|
2020-12-01 |
4 |
S |
$45.16 |
$45,160 |
D/D |
(1,000) |
432,689 |
|
-91% |
|
Xie Jian |
Chief Operating Officer |
|
2020-11-30 |
4 |
S |
$43.17 |
$146,762 |
D/D |
(3,396) |
433,689 |
|
-83% |
|
Xie Jian |
Chief Operating Officer |
|
2020-11-23 |
4 |
S |
$44.08 |
$264,480 |
D/D |
(6,000) |
437,085 |
|
-113% |
|
Xie Jian |
Chief Operating Officer |
|
2020-11-20 |
4 |
S |
$42.50 |
$42,500 |
D/D |
(1,000) |
443,085 |
|
-125% |
|
Xie Jian |
Chief Operating Officer |
|
2020-11-18 |
4 |
S |
$44.83 |
$134,500 |
D/D |
(3,000) |
444,085 |
|
-123% |
|
Xie Jian |
Chief Operating Officer |
|
2020-11-17 |
4 |
S |
$44.61 |
$168,012 |
D/D |
(3,706) |
447,085 |
|
-108% |
|
Bolger John C |
Director |
|
2020-11-17 |
4 |
S |
$44.24 |
$188,877 |
D/D |
(4,269) |
375 |
|
-108% |
|
Bolger John C |
Director |
|
2020-11-17 |
4 |
OE |
$0.38 |
$1,000 |
D/D |
2,631 |
4,644 |
|
- |
|
281 Records found
|
|
Page 8 of 12 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|